Hykes Andrew

About Hykes Andrew

Drew Hykes is the Chief Executive Officer and President of Inari Medical, Inc., and he has also served on the company’s Board of Directors since January 2023. In his current role, he leads overall strategy, commercial execution, and operations at a U.S.-listed medical device company focused on venous disease and, more recently, on broader vascular therapy platforms. Public company filings and company disclosures describe him as a proven operating executive with broad functional, geographic, and sector experience, especially in medical devices and international commercialization. Before becoming CEO, Mr. Hykes held progressively broader leadership roles at Inari Medical. He served as Chief Operating Officer from 2020 through 2022, and before that as Chief Commercial Officer beginning in 2017. As COO, he oversaw day-to-day business operations and had responsibility for research, product development, manufacturing, operations, quality, and regulatory functions. As CCO, he led the initial commercialization of Inari’s solutions in the U.S. market. This internal progression reflects a long runway of operational leadership and a deep understanding of the company’s commercial and product development model. Prior to joining Inari, he was Vice President of Commercial Operations at Sequent Medical, where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype stage to broader adoption in Europe. Earlier in his career, he spent 11 years at Medtronic in a series of roles that included Vice President of Marketing for the AF Solutions business, Vice President of Clinical and Regulatory for AF Solutions, and Director of Investor Relations. He also spent three years on expatriate assignment in Europe, where he helped lead the launch of Medtronic’s first drug-eluting coronary stent. Before Medtronic, he worked at ABN AMRO Bank in Chicago, focused on healthcare transactions. His background points to a leadership profile centered on commercial scaling, product launch execution, regulatory navigation, and international market development. Notable actions during his tenure include helping scale Inari’s operating capabilities, supporting the company’s growth trajectory, and advancing strategic initiatives such as the acquisition and integration of LimFlow. He holds a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.